My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 250

    1.

    Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

    Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G.

    Diabetes. 2005 Dec;54(12):3541-6.PMID: 16306373 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.

    Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G.

    Diabetes Care. 2007 May;30(5):1212-8. Epub 2007 Feb 2.PMID: 17277038 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.

    Guzder RN, Gatling W, Mullee MA, Byrne CD.

    Diabetologia. 2006 Jan;49(1):49-55. Epub 2005 Dec 10.PMID: 16341841 [PubMed - indexed for MEDLINE]Related articles

    4.

    Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.

    Targher G, Bertolini L, Padovani R, Poli F, Scala L, Tessari R, Zenari L, Falezza G.

    Diabet Med. 2006 Apr;23(4):403-9.PMID: 16620269 [PubMed - indexed for MEDLINE]Related articles

    5.

    The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

    Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

    Diabet Med. 2004 Jan;21(1):52-8.PMID: 14706054 [PubMed - indexed for MEDLINE]Related articles

    6.

    Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

    Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T.

    World J Gastroenterol. 2007 Mar 14;13(10):1579-84.PMID: 17461452 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.

    Targher G, Bertolini L, Padovani R, Poli F, Scala L, Zenari L, Zoppini G, Falezza G.

    J Endocrinol Invest. 2006 Jan;29(1):55-60.PMID: 16553034 [PubMed - indexed for MEDLINE]Related articles

    8.

    HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.

    Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M.

    Diabetes Care. 2002 Jul;25(7):1135-41.PMID: 12087010 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.

    Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H.

    Cardiovasc Diabetol. 2006 Jul 17;5:15.PMID: 16842631 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.

    Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M.

    Diabetologia. 2008 Mar;51(3):444-50. Epub 2007 Dec 6.PMID: 18058083 [PubMed - indexed for MEDLINE]Related articles

    11.

    Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.

    Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G.

    Diabet Med. 2008 Jan;25(1):45-50.PMID: 18199131 [PubMed - indexed for MEDLINE]Related articles

    12.

    The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.

    Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabetes Care. 2007 May;30(5):1206-11. Epub 2007 Jan 26.PMID: 17259472 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.

    Rius Riu F, Salinas Vert I, Lucas Martín A, Romero González R, Sanmartí Sala A.

    J Diabetes Complications. 2003 Sep-Oct;17(5):235-42.PMID: 12954150 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]

    Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS.

    Korean J Hepatol. 2008 Mar;14(1):77-88. Korean. PMID: 18367860 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease.

    Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S.

    Circulation. 2008 Jul 15;118(3):277-83. Epub 2008 Jun 30.PMID: 18591439 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.

    Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB Sr, Wilson PW.

    Diabetes Care. 2007 May;30(5):1219-25. Epub 2007 Jan 26.PMID: 17259468 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.

    Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study.

    Diabetes Care. 2005 Jun;28(6):1463-71.PMID: 15920069 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    C-reactive protein and incident cardiovascular events among men with diabetes.

    Schulze MB, Rimm EB, Li T, Rifai N, Stampfer MJ, Hu FB.

    Diabetes Care. 2004 Apr;27(4):889-94.PMID: 15047644 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

    Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB.

    Diabetes Care. 2004 Aug;27(8):1991-7.PMID: 15277429 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.

    Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, Arcaro G.

    Diabetes Care. 2006 Jun;29(6):1325-30.PMID: 16732016 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity